Evidence map›Paper›PMID 35799850›Full record

ArticleData in brief2022

Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods.

Michael C Thrun, Jörg Hoffmann, Maximilian Röhnert, Malte von Bonin, Uta Oelschlägel, Cornelia Brendel, Alfred Ultsch

Abstract read
In one paragraph

Article in Data in brief, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael C ThrunDatabionics, Mathematics and Computer Science, Philipps-Universität Marburg, Hans-Meerwein-Straße 6 D-35032 Marburg, Germany.
Jörg HoffmannJ Department of Hematology, Oncology and Immunology, Philipps-University, Baldinger Str., D-35032 Marburg, Germany.
Maximilian RöhnertMedizinische Klinik und Poliklinik I Bereich Innere Medizin / Hämatologie und Onkologie, Universitätsklinikum Carl Gustav Carus Dresden, Germany.
Malte von BoninMedizinische Klinik und Poliklinik I Bereich Innere Medizin / Hämatologie und Onkologie, Universitätsklinikum Carl Gustav Carus Dresden, Germany.
Uta OelschlägelMedizinische Klinik und Poliklinik I Bereich Innere Medizin / Hämatologie und Onkologie, Universitätsklinikum Carl Gustav Carus Dresden, Germany.
Cornelia BrendelJ Department of Hematology, Oncology and Immunology, Philipps-University, Baldinger Str., D-35032 Marburg, Germany.
Alfred UltschDatabionics, Mathematics and Computer Science, Philipps-Universität Marburg, Hans-Meerwein-Straße 6 D-35032 Marburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three different Flow Cytometry datasets consisting of diagnostic samples of either peripheral blood (pB) or bone marrow (BM) from patients without any sign of bone marrow disease at two different health care centers are provided. In Flow Cytometry, each cell rapidly passes through a laser beam one by one, and two light scatter, and eight surface parameters of more than 100.000 cells are measured per sample of each patient. The technology swiftly characterizes cells of the immune system at the single-cell level based on antigens presented on the cell surface that are targeted by a set of fluorochrome-conjugated antibodies. The first dataset consists of N=14 sample files measured in Marburg and the second dataset of N=44 data files measured in Dresden, of which half are BM samples and half are pB samples. The third dataset contains N=25 healthy bone marrow samples and N=25 leukemia bone marrow samples measured in Marburg. The data has been scaled to log between zero and six and used to identify cell populations that are simultaneously meaningful to the clinician and relevant to the distinction of pB vs BM, and BM vs leukemia. Explainable artificial intelligence methods should distinguish these samples and provide meaningful explanations for the classification without taking more than several hours to compute their results. The data described in this article are available in Mendeley Data [1].

Indexed as

BenchmarkingCell populationsExplainable artificial intelligenceFlow cytometryHuman bloodHuman bone marrowImmunophenotypingInterpretable machine learning

Identifiers

PMID35799850
PMCPMC9253476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.